Altered decorin expression of systemic sclerosis by UVA1 (340-400 nm) phototherapy: Immunohistochemical analysis of 3 cases

BMC Dermatology

Volumn 3, Issue , 2003, Pages

  Sawada, Hiroo ^a   Isogai, Zenzo ^a   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN FIBRIL; DECORIN; DERMATAN SULFATE; MONOCLONAL ANTIBODY; PROTEOGLYCAN; SCLEROPROTEIN;

ARTICLE; BIOACCUMULATION; CASE REPORT; CONTROLLED STUDY; DERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHOTOTHERAPY; PROTEIN BINDING; PROTEIN EXPRESSION; SKIN BIOPSY; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; AGED; METABOLISM; METHODOLOGY; MIDDLE AGED;

AGED; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTEOGLYCANS; SCLERODERMA, SYSTEMIC; ULTRAVIOLET THERAPY;

EID: 2442641533     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-3-2     Document Type: Article

References (21)

1. Krusius T and Ruoslahti E Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A 1986, 83:7683-7687
2. Iozzo RV The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999, 274:18843-18846
3. Schmidt G, Robenek H, Harrach B, Glossl J, Nolte V, Hormann H, Richter H and Kresse H Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol 1987, 104:1683-1691
4. Winnemoller M, Schon P, Vischer P and Kresse H Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 1992, 59:47-55
5. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ and Iozzo RV Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998, 101:406-412
6. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD and Ruoslahti E Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 1992, 360:361-364
7. Takeuchi Y, Kodama Y and Matsumoto T Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J Biol Chem 1994, 269:32634-32638
8. Kuroda K and Shinkai H Decorin and glycosaminoglycan synthesis in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997, 289:481-485
9. Kuroda K and Shinkai H Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997, 289:567-572
10. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A and Schopf E High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992, 26:225-230
11. Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, Morita A and Krutmann J Ultraviolet AI (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999, 41:47-50
12. Stege H, Schopf E, Ruzicka T and Krutmann J High-dose UVAI for urticaria pigmentosa. Lancet 1996, 347:64
13. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, Boedeker R, Diepgen T, Dierks K and Goerz G High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997, 36:938-944
14. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB and Varga J Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992, 128:337-346
15. Morita A, Kobayashi K, Isomura I, Tsuji T and Krutmann J Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000, 43:670-674
16. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, Dirschka T and Altmeyer P Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998, 38:21-26
17. Kreuter A, Gambichler T, Avermaete A, Happe M, Bacharach-Buhles M, Hoffmann K, Jansen T, Altmeyer P and von Kobyletzki G Lowdose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002, 46:251-255
18. Yin L, Yamauchi R, Tsuji T, Krutmann J and Morita A The Expression of Matrix Metalloproteinase-1 mRNA Induced by Ultraviolet AI (340-400 nm) Is Phototherapy Relevant to the Glutathione (GSH) Content in Skin Fibroblasts of Systemic Sclerosis. J Dermatol 2003,
19. Morita A and Krutmann J Ultraviolet A radiation-induced apoptosis. Methods Enzymol 2000, 319:302-309
20. Sobue M, Nakashima N, Fukatsu T, Nagasaka T, Katoh T, Ogura T and Takeuchi J Production and characterization of monoclonal antibody to dermatan sulfate proteoglycan. J Histochem Cytochem 1988, 36:479-485
21. Sawada H, Shinomura T, Kimata K, Takeuchi J, Tsuji T and Watanabe H Characterization of an anti-decorin monoclonal antibody, and its utility. J Biochem (Tokyo) 2002, 132:997-100